Derma Sciences
DSCI
DSCI was delisted on the 23rd of February, 2017.
62 hedge funds and large institutions have $174M invested in Derma Sciences in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 18 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 19
1.71% less ownership
Funds ownership: 83.87% → 82.16% (-1.7%)
6% less funds holding
Funds holding: 66 → 62 (-4)
14% less capital inflows, than outflows
Capital inflows: $25.7M | Capital outflows: $29.9M
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.03M |
| 2 |
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.16M |
| 3 |
Millennium Management
New York
|
+$2.04M |
| 4 |
Renaissance Technologies
New York
|
+$1.81M |
| 5 |
Goldman Sachs
New York
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HealthCor Management
New York
|
-$7.57M |
| 2 |
Great Point Partners
Greenwich,
Connecticut
|
-$5.25M |
| 3 |
BlackRock Fund Advisors
San Francisco,
California
|
-$4.22M |
| 4 |
OrbiMed
New York
|
-$2.54M |
| 5 |
JP Morgan Chase
New York
|
-$1.9M |
DSCI Hedge Fund Activity: Q2 2015 in Review
62 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences (DSCI) for Q2 2015, worth a combined $174M — down 4.5% from $183M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of DSCI and 14 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 24 added.
The largest buyer was Fidelity Investments, adding an estimated $4.03M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.57M sold.
- 62 institutional investors held Derma Sciences (DSCI) as of Q2 2015, down from 66 in Q1 2015.
- Funds reported $174M of Derma Sciences stock for Q2 2015, down 4.5% quarter-over-quarter.
- 14 funds opened new Derma Sciences positions in Q2 2015 and 18 closed out, a net change of -4 holders.
- The largest Derma Sciences buyer in Q2 2015 was Fidelity Investments, an estimated $4.03M added.
- The largest Derma Sciences seller in Q2 2015 was HealthCor Management, an estimated $7.57M sold.
Based on aggregated 13F filings for Q2 2015.